5HTTLPR Genetic Variant and Major Depressive Disorder: A Review.
Caroline Ferreira FratelliJhon SiqueiraCalliandra Maria de Souza SilvaEduardo Antônio FerreiraIzabel Cristina Rodrigues Da SilvaPublished in: Genes (2020)
Major Depressive Disorder (MDD) is a disease that involves biological, psychological, and social interactions. Studies have shown the importance of genetics contribution to MDD development. The SCL6A4 protein (5HTTLPR) functions transporting serotonin, a neurotransmitter linked to mood and emotion, to the synaptic cleft. Hence, this study seeks, through a literature review, a better comprehension of the 5HTTLPR genetic variant association with MDD. For this purpose, a search was performed on the Virtual Health Library Portal for articles that related 5HTTLPR to MDD. Most of the articles found were conducted in the American continent, with one (1) study implemented in Brazil. 5HTTLPR associations were found regarding changes in the nervous system, pharmacology, and risk factors seen in MDD patients. When verifying the allelic distribution, the S allele had a higher frequency in most of the studies analyzed. Despite not finding a commonality in the different studies, the tremendous genetic variation found demonstrates the MDD complexity. For this reason, further studies in diverse populations should be conducted to assist in the understanding and treatment of the disease.
Keyphrases
- major depressive disorder
- bipolar disorder
- case control
- risk factors
- end stage renal disease
- chronic kidney disease
- public health
- mental health
- ejection fraction
- depressive symptoms
- genome wide
- copy number
- autism spectrum disorder
- dna methylation
- gene expression
- small molecule
- binding protein
- genetic diversity
- smoking cessation
- human health